As more drug makers adopt pharmaceutical continuous manufacturing, new technological developments and operational demands are resulting from new partnerships among academic centers and industry leaders, particularly in the past two years. To this goal, USP recently formalized collaborations with Center for Structured Organic Particulate Systems (C-SOPS), a leader in research on PCM. Learn more about the opportunities in this field.
Participants in USP’s Global Fellowship Program are making important scientific contributions in a number of critical areas thanks to the organization’s ongoing commitment to scientific mentorship. Read about USP’s 2016 global fellows and their important contributions that have great potential to improve public health.
Dr. Wesley (Wes) Workman, USP Volunteer and Chair, General Chapters–Biological Analysis Expert Committee reflects on his volunteer role at USP and his work with what he refers to as the "dream team" of the heparin world.
Although women comprise a majority of the global health workforce, they are under-represented at the decision-making level of global policy and governance. This workforce pipeline challenge was a focus of recent remarks by the President of Mauritius, Her Excellency Ameenah Gurib-Fakim, during an event hosted by USP’s CePAT in Ghana to celebrate African women leaders in pharmacuetical regulatory affairs.
Nanomedicine—the use of nanoscale materials and technologies to treat diseases at the molecular level—has shown promising results in patient care, particularly in oncology. While this potential has led to increased research, there are challenges surrounding nomenclature, characterization and environmental impact. Learn how you can collaborate with USP to help determine a path foward.
Over-the-counter (OTC) medicines, drugs available to consumers/patients without a prescription, play an important role in our modern healthcare system. An upcoming Consumer Healthcare Products Association workshop highlights how USP collaborates with key stakeholders to help address specific needs in OTC manufacturing and testing related to drug quality. Learn more.
Learn about USP's involvement in the APEC Life Sciences Innovation Forum and how this group is improving access to quality medical products by helping Asian-Pacific economies prevent, detect and respond to spurious, substandard, falsified, falsely-labelled and counterfeit products in their supply chains.
Anthony Lakavage, Senior Vice President, USP Global External Affairs, shares insights on USP–India's 10th Anniversary and how USP is working globally to increase its impact on improving the quality of medicines, dietary supplements and foods worldwide.
With assistance from USP's Promoting the Quality of Medicines (PQM) program, Guatemala’s official medicines control laboratory has retained their ISO 17025 accreditation, a major milestone in its quest to combat the proliferation of poor quality medicines within its borders.